Loading organization details...
The organization you're looking for doesn't exist or has been removed.
Back to Organizations| Sub-Organization | Type | Status | Funding |
|---|
| Announced Date | Transaction Name | Investors | Money Raised | Lead Investors | Funding Type |
|---|
| Investor Name | Lead Investor | Funding Round | Partners |
|---|
| Organization Name | Lead Investor | Funding Round |
|---|
| Announced Date | Organization Name | Diversity Spotlight | Funding Round | Money Raised |
|---|
| Acquiree Name | Announced Date | Price | Transaction Name |
|---|
Matched by industry, location, employee size, and funding stage.
Huntingdon
Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
Canonical: https://fsome.com/organization/apini-therapeutics-23045 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.
Sign in to view detailed metrics, contact information, and financial data. Upgrade your account to access the full dataset — including funding history, team contacts, and real-time company insights.